Geraldine Pannu is of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 57,613 shares of PCSA, which is worth approximately $51,851. The most recent transaction as insider was on Oct 10, 2023, when has been sold 4,500 shares (Common Stock) at a price of $0.21 per share, resulting in proceeds of $945. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.6K
0% 3M change
0% 12M change
Total Value Held $51,851

Geraldine Pannu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 10 2023
BUY
Grant, award, or other acquisition
$945 $0.21 p/Share
4,500 Added 7.24%
57,613 Common Stock
Jun 27 2023
BUY
Exercise of conversion of derivative security
-
23,636 Added 30.8%
53,113 Common Stock
Dec 31 2022
BUY
Exercise of conversion of derivative security
-
18,208 Added 38.18%
29,477 Common Stock
Aug 05 2022
BUY
Exercise of conversion of derivative security
-
1,169 Added 9.4%
11,269 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
4,393 Added 30.31%
10,100 Common Stock
Aug 05 2021
BUY
Grant, award, or other acquisition
-
1,169 Added 17.0%
5,707 Common Stock

Also insider at

RBB
RBB Bancorp Financial Services
GP

Geraldine Pannu

Hanover, MD

Track Institutional and Insider Activities on PCSA

Follow Processa Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

News

Receive news related to Processa Pharmaceuticals, Inc.

Track Activities on PCSA